Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Oct;39(4):562–568. doi: 10.1136/gut.39.4.562

Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.

T Zimmer 1, U Stölzel 1, M Bäder 1, K Koppenhagen 1, B Hamm 1, H Buhr 1, E O Riecken 1, B Wiedenmann 1
PMCID: PMC1383270  PMID: 8944566

Abstract

BACKGROUND: Endoscopic ultrasonography (EUS) and somatostatin receptor scintigraphy (SRS) can detect a high percentage of gastroenteropancreatic neuroendocrine tumours especially in the upper gastrointestinal tract. The ability of these procedures to localise primary tumour lesions and metastases of gastrinomas and insulinomas was evaluated in comparison with transabdominal ultrasonography (US), computed tomography (CT) and magnetic resonance imaging (MRI). PATIENTS AND METHODS: In a prospective trial, patients with gastrinomas (n = 10) and insulinomas (n = 10) diagnosed by clinical signs and laboratory tests were assessed by EUS, SRS, US, CT and MRI. RESULTS: In 10 patients with gastrinoma and 10 patients with insulinoma, a total of 14 separate primary tumour lesions were histologically confirmed for each of the tumour entities. The mean diameter was 2.1 cm for gastrinomas and 1.5 cm for insulinomas. All insulinomas and nine gastrinoma lesions were located in the pancreas. Three gastrinomas were found in the duodenal wall, one in a periduodenal lymph node, and one in the liver, For gastrinomas, sensitivities were 79% with EUS, 86% with SRS and 29% with CT, US, and MRI. For insulinomas, sensitivities were 93% with EUS, 14% with SRS, 21% with CT and 7% with US and MRI. CONCLUSIONS: EUS is of high value for localising primary lesions of both tumour entities. SRS is a very sensitive procedure for diagnosing of gastrinomas but not insulinomas. CT, US and MRI are primarily useful for visualising metastases.

Full text

PDF
562

Images in this article

565Figure 1
on p.565
566Figure 2
on p.566

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broughan T. A., Leslie J. D., Soto J. M., Hermann R. E. Pancreatic islet cell tumors. Surgery. 1986 Jun;99(6):671–678. [PubMed] [Google Scholar]
  2. ELLISON E. H., WILSON S. D. THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES. Ann Surg. 1964 Sep;160:512–530. doi: 10.1097/00000658-196409000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fraker D. L., Norton J. A. The role of surgery in the management of islet cell tumors. Gastroenterol Clin North Am. 1989 Dec;18(4):805–830. [PubMed] [Google Scholar]
  4. Frucht H., Doppman J. L., Norton J. A., Miller D. L., Dwyer A. J., Frank J. A., Vinayek R., Maton P. N., Jensen R. T. Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology. 1989 Jun;171(3):713–717. doi: 10.1148/radiology.171.3.2655004. [DOI] [PubMed] [Google Scholar]
  5. Frucht H., Norton J. A., London J. F., Vinayek R., Doppman J. L., Gardner J. D., Jensen R. T., Maton P. N. Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology. 1990 Dec;99(6):1622–1627. doi: 10.1016/0016-5085(90)90466-e. [DOI] [PubMed] [Google Scholar]
  6. Galiber A. K., Reading C. C., Charboneau J. W., Sheedy P. F., 2nd, James E. M., Gorman B., Grant C. S., van Heerden J. A., Telander R. L. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology. 1988 Feb;166(2):405–408. doi: 10.1148/radiology.166.2.2827232. [DOI] [PubMed] [Google Scholar]
  7. Glover J. R., Shorvon P. J., Lees W. R. Endoscopic ultrasound for localisation of islet cell tumours. Gut. 1992 Jan;33(1):108–110. doi: 10.1136/gut.33.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Höring E., Räth U., Rücker S., von Gaisberg U., Meincke J., Walendzik J., Dörr U., Bihl H. Somatostatinrezeptor-Szintigraphie in der Primärdiagnostik und Nachsorge bei Gastrinomen. Dtsch Med Wochenschr. 1994 Mar 18;119(11):367–374. doi: 10.1055/s-2008-1058703. [DOI] [PubMed] [Google Scholar]
  9. Jamar F., Fiasse R., Leners N., Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med. 1995 Apr;36(4):542–549. [PubMed] [Google Scholar]
  10. John M., Meyerhof W., Richter D., Waser B., Schaer J. C., Scherübl H., Boese-Landgraf J., Neuhaus P., Ziske C., Mölling K. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut. 1996 Jan;38(1):33–39. doi: 10.1136/gut.38.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Joseph K., Stapp J., Reinecke J., Höffken H., Benning R., Neuhaus C., Trautmann M. E., Schwerk W. B., Arnold R. Rezeptorszintigraphie bei endokrinen gastroenteropankreatischen Tumoren. Dtsch Med Wochenschr. 1992 Jun 26;117(26):1025–1028. doi: 10.1055/s-2008-1062406. [DOI] [PubMed] [Google Scholar]
  12. Krenning E. P., Bakker W. H., Breeman W. A., Koper J. W., Kooij P. P., Ausema L., Lameris J. S., Reubi J. C., Lamberts S. W. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989 Feb 4;1(8632):242–244. doi: 10.1016/s0140-6736(89)91258-0. [DOI] [PubMed] [Google Scholar]
  13. Krenning E. P., Kwekkeboom D. J., Oei H. Y., de Jong R. J., Dop F. J., Reubi J. C., Lamberts S. W. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann N Y Acad Sci. 1994 Sep 15;733:416–424. doi: 10.1111/j.1749-6632.1994.tb17291.x. [DOI] [PubMed] [Google Scholar]
  14. Krenning E. P., Kwekkeboom D. J., Reubi J. C., Van Hagen P. M., van Eijck C. H., Oei H. Y., Lamberts S. W. 111In-octreotide scintigraphy in oncology. Metabolism. 1992 Sep;41(9 Suppl 2):83–86. doi: 10.1016/0026-0495(92)90038-c. [DOI] [PubMed] [Google Scholar]
  15. Krudy A. G., Doppman J. L., Jensen R. T., Norton J. A., Collen M. J., Shawker T. H., Gardner J. D., McArthur K., Gorden P. Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography, and venous sampling. AJR Am J Roentgenol. 1984 Sep;143(3):585–589. doi: 10.2214/ajr.143.3.585. [DOI] [PubMed] [Google Scholar]
  16. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990 Nov 1;323(18):1246–1249. doi: 10.1056/NEJM199011013231805. [DOI] [PubMed] [Google Scholar]
  17. Lamberts S. W., Hofland L. J., van Koetsveld P. M., Reubi J. C., Bruining H. A., Bakker W. H., Krenning E. P. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab. 1990 Sep;71(3):566–574. doi: 10.1210/jcem-71-3-566. [DOI] [PubMed] [Google Scholar]
  18. Lightdale C. J., Botet J. F., Woodruff J. M., Brennan M. F. Localization of endocrine tumors of the pancreas with endoscopic ultrasonography. Cancer. 1991 Oct 15;68(8):1815–1820. doi: 10.1002/1097-0142(19911015)68:8<1815::aid-cncr2820680828>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  19. Palazzo L., Roseau G., Salmeron M. Endoscopic ultrasonography in the preoperative localization of pancreatic endocrine tumors. Endoscopy. 1992 May;24 (Suppl 1):350–353. doi: 10.1055/s-2007-1010498. [DOI] [PubMed] [Google Scholar]
  20. Pipeleers-Marichal M., Somers G., Willems G., Foulis A., Imrie C., Bishop A. E., Polak J. M., Häcki W. H., Stamm B., Heitz P. U. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990 Mar 15;322(11):723–727. doi: 10.1056/NEJM199003153221103. [DOI] [PubMed] [Google Scholar]
  21. Roche A., Raisonnier A., Gillon-Savouret M. C. Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases. Radiology. 1982 Dec;145(3):621–627. doi: 10.1148/radiology.145.3.6292994. [DOI] [PubMed] [Google Scholar]
  22. Ruszniewski P., Amouyal P., Amouyal G., Grangé J. D., Mignon M., Bouché O., Bernades P. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery. 1995 Jun;117(6):629–635. doi: 10.1016/s0039-6060(95)80005-0. [DOI] [PubMed] [Google Scholar]
  23. Rösch T., Lightdale C. J., Botet J. F., Boyce G. A., Sivak M. V., Jr, Yasuda K., Heyder N., Palazzo L., Dancygier H., Schusdziarra V. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992 Jun 25;326(26):1721–1726. doi: 10.1056/NEJM199206253262601. [DOI] [PubMed] [Google Scholar]
  24. Scherübl H., Bäder M., Fett U., Hamm B., Schmidt-Gayk H., Koppenhagen K., Dop F. J., Riecken E. O., Wiedenmann B. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology. 1993 Dec;105(6):1705–1709. doi: 10.1016/0016-5085(93)91066-q. [DOI] [PubMed] [Google Scholar]
  25. Stark D. D., Moss A. A., Goldberg H. I., Deveney C. W. CT of pancreatic islet cell tumors. Radiology. 1984 Feb;150(2):491–494. doi: 10.1148/radiology.150.2.6318260. [DOI] [PubMed] [Google Scholar]
  26. Sugg S. L., Norton J. A., Fraker D. L., Metz D. C., Pisegna J. R., Fishbeyn V., Benya R. V., Shawker T. H., Doppman J. L., Jensen R. T. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg. 1993 Aug;218(2):138–144. doi: 10.1097/00000658-199308000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thompson N. W., Czako P. F., Fritts L. L., Bude R., Bansal R., Nostrant T. T., Scheiman J. M. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery. 1994 Dec;116(6):1131–1138. [PubMed] [Google Scholar]
  28. Wank S. A., Doppman J. L., Miller D. L., Collen M. J., Maton P. N., Vinayek R., Slaff J. I., Norton J. A., Gardner J. D., Jensen R. T. Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology. 1987 Apr;92(4):905–912. doi: 10.1016/0016-5085(87)90963-2. [DOI] [PubMed] [Google Scholar]
  29. Westlin J. E., Ahlström H., Ylä-Jäski J., Oberg K., Nilsson S. Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumours. Acta Oncol. 1993;32(2):171–176. doi: 10.3109/02841869309083908. [DOI] [PubMed] [Google Scholar]
  30. Zimmer T., Ziegler K., Bäder M., Fett U., Hamm B., Riecken E. O., Wiedenmann B. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut. 1994 Apr;35(4):471–475. doi: 10.1136/gut.35.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. de Kerviler E., Cadiot G., Lebtahi R., Faraggi M., Le Guludec D., Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. Eur J Nucl Med. 1994 Nov;21(11):1191–1197. doi: 10.1007/BF00182352. [DOI] [PubMed] [Google Scholar]
  32. van Heerden J. A., Grant C. S., Czako P. F., Service F. J., Charboneau J. W. Occult functioning insulinomas: which localizing studies are indicated? Surgery. 1992 Dec;112(6):1010–1015. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES